Head of Research Division of @GustaveRoussy , @myesmo President
- Tweets 3,176
- Following 499
- Followers 15,281
- Likes 1,076
FabriceAndre retweeted
ESMO's new Clinical Trials Funding initiative supports independent academic pragmatic clinical trials to improve #CancerCare and patient outcomes. Open to academic institutions, hospitals, research groups.
Application deadline: 1 November 2026
ow.ly/482Q50ZLX3p
1
18
42
15,327
.@esmo_iotech publishes innovations in immuno-oncology. high quality papers under the leadership of @LoiSher and @HaanenJohn
🚩Can an mRNA vaccine make “cold” tumours more responsive to immunotherapy 🌶️?
A recent @Nature study suggests mRNA vaccination may activate systemic innate immunity & potentially sensitise tumours to checkpoint blockade.
The clinical data need prospective validation, but the biological concept is compelling.
The Authors discuss the implications in an @esmo_iotech commentary. 🙏@adam_grippin @StevenLin_MDPhD
Nature article linked: nature.com/articles/s41586-0…
IOTECH commentary: esmoiotech.org/article/S2590…
@myESMO @esmo_iotech #CancerImmunotherapy #mRNA #ImmunoOncology #ESMO #ESMOIOTECH
5
9
2,984
FabriceAndre retweeted
I enjoyed going through this paper by @FerMosele and @GustaveRoussy team. It outlines a roadmap for the future of ADCs from soup to nuts. It was just published in @NatureMedicine —a must read for everyone with @FIFAWorldCup ⚽️ withdrawal!
Link: nature.com/articles/s41591-0…
3
32
112
10,207
EN DIRECT | Cérémonie en hommage aux victimes de l’attentat du 14 juillet 2016 à Nice. nitter.net/i/broadcasts/1nJOLLqdb…
145
190
543
87,154
FabriceAndre retweeted
Wow! Not 1️⃣, not 2️⃣, but 3️⃣‼️@Nature papers concomitantly published during #ESMO25 @myESMO
@LoiSher @adam_grippin @MDAndersonNews @PeterMacCC @NKI_nl @DrChoueiri @VanAllenLab @FAndreMD congrats to all authors and 🙏 for making this very unique session happen also @Nature ! 👇
6
31
140
16,388
FabriceAndre retweeted
📣 ESMOImmuno25: Aurélien Marabelle, Scientific Co-Chair, invites you to present your research to an international audience of top-tier scientists, clinicians, and industry experts.
⏰ Deadline: 30 September 2025
🔗 ow.ly/PXBG50WnEQ4
1
5
14
3,351
FabriceAndre retweeted
📣 Join us in Hong Kong for a chance to contribute to oncology drug development in Asia Pacific!
⏰ Late registration deadline: 18 June
🔗 ow.ly/MWyG50W90Ef
@herbloong @TonyMok9 @DrBenTran @AyaHelali
7
24
2,837
FabriceAndre retweeted
At #ASCO25, the Joint Session between ASCO and @myESMO will discuss emerging trends & the implications of integrating biomarker testing into clinical care. #ASCODailyNews has more on this with: @ASCOPres @BenWestphalen @FAndreMD @DrBonillaOnc @jrgralow: brnw.ch/21wSLDe
2
20
54
6,627
FabriceAndre retweeted
#ESMOBreast25 is next month. Love this "digestible" breast only meeting with the benefits of extra interaction with all of our international colleagues.
Registration: esmo.org/meeting-calendar/es…
Program: cslide.ctimeetingtech.com/co…
#bcsm @myESMO @curijoey @FAndreMD
2
16
74
4,402
FabriceAndre retweeted
📢 #ESMOFellowship applications are now open!
The Society is committed to supporting #YoungOncologists in developing high-quality #TranslationalResearch or #ClinicalResearch projects.
📅 Apply by: 29 May 2025
🔗 ow.ly/tz3e50VAQuM
@E_de_Azambuja @TeresaSAmaral
16
44
14,438
It was very sad to learn that M Schneider passed away. Maurice created @myESMO in 1975 together with G Mathe, in @VilledeNice
50 years later, @myESMO includes almost 45k members around the 🌍, trains all generations of doctors and transforms practice of oncology w its frameworks
ESMO pays tribute to Dr Maurice Schneider who dedicated his life to advancing oncology. His efforts were instrumental in paving the way for future generations of medical oncology professionals across Europe.
7
8
66
3,976
FabriceAndre retweeted
📣ESMO #ClinicalPracticeGuideline Express Update on #PancreaticCancer: updated 1st- & #2nd-line treatment recommendations for managing #MetastaticPancreaticCancer, following approval of 1st-line nanoliposomal #irinotecan. #ESMOGuidelines
🔗ow.ly/H7Ap50Vx9Qj
2
18
44
8,035
FabriceAndre retweeted
👉 Share your findings with regional and international experts in #cancer #drugdevelopment.
⏰ You still have 3 weeks to submit your abstract to #ESMOTATAsia25, a new platform to improve cancer care in the region
Submit now:
🔗 ow.ly/iagq50VuAmn
9
17
2,417
FabriceAndre retweeted
Abstract submission now open for #ESMO25 in #BERLIN! We have a fantastic educational programme in place, and now it's time for the scientific programme.
Looking forward to your abstracts!
Deadline: May13th esmo.org/meeting-calendar/es… @DrChoueiri @myESMO @DrChoueiri @FAndreMD
4
38
111
13,844
FabriceAndre retweeted
📣 Join us for an insightful ESMO Webinar on Advanced Urothelial Cancer!
👩⚕️Our expert panel will discuss 1st & 2nd line therapies, toxicity management & more. Live Q&A included.
👉Register now!
#UrothelialCancer
🔗ow.ly/Etpg50V07hR
10
21
3,937
FabriceAndre retweeted
📣 ESMO #ClinicalPracticeGuideline eUpdate on #OesophagealCancer: in resectable, locally advanced oesophageal adenocarcinoma or OGJ pre- & post-operative #chemotherapy is associated with improved survival vs #Neoadjuvant #Chemoradiotherapy.
🔗 ow.ly/R37w50UYlE9
2
21
29
3,300
FabriceAndre retweeted
Opening session of #ESMOAFrica2025 by the @myESMO president @FAndreMD with the amazing audience from all over Africa. @OncoAlert @curijoey @E_de_Azambuja
1
4
19
1,513
FabriceAndre retweeted
Get the latest in early clinical trials at ESMO TAT 2025, from bispecific antibodies for IO, cell therapies in solid tumours (CART, NK cells, modified TCRs, TIL therapy) to MAPkinase pathway and associated targets (KRAS G12C, MAP2K4, combos). Register now!
2
22
121
434,672
FabriceAndre retweeted
ESMO announces @Philippe_Bedard as the recipient of the 2025 TAT Honorary Award for his outstanding contributions to advancing targeted anticancer therapies.
📅 He will deliver his award lecture on 3 March at the #ESMOTAT25 in Paris
📌 ow.ly/eue550UT7eX
3
11
42
3,438